Moderna Inc (NASDAQ:MRNA)
| 142.85 Delayed Data As of Jun 30 |  +0.04 / +0.03%Today’s Change | 115.61 Today|||52-Week Range 497.49 | -43.76% Year-to-Date |
Latest MRNA News | Press Releases
| Could This Send Moderna's Stock Soaring Back to $400? Jun 30 / MotleyFool.com - Paid Partner Content | FDA Panel Recommends Modifying COVID Jabs to Target Omicron Jun 29 / Zacks.com - Paid Partner Content |
| Is Pfizer Stock a Buy Now? Jun 30 / MotleyFool.com - Paid Partner Content | 2 Dividend Stocks With Huge Passive Income Potential Jun 29 / MotleyFool.com - Paid Partner Content |
| 3 Things About Moderna That Smart Investors Know Jun 30 / MotleyFool.com - Paid Partner Content | The 3 Smartest Real Estate Stocks to Buy Right Now Jun 28 / MotleyFool.com - Paid Partner Content |
| Pfizer (PFE) Inks Deal With US Government for COVID Jab Supply Jun 30 / Zacks.com - Paid Partner Content | Moderna (MRNA) Gains As Market Dips: What You Should Know Jun 27 / Zacks.com - Paid Partner Content |
| The Chef's Warehouse and AZEK have been highlighted as Zacks Bull and Bear of the Day Jun 30 / Zacks.com - Paid Partner Content | Pfizer's (PFE) Omicron-Based COVID Shot Betters Immune Response Jun 27 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 142.81 |
| Today’s open | 143.32 |
| Day’s range | 135.57 - 147.30 |
| Volume | 185,610 |
| Average volume (3 months) | 6,676,451 |
| Market cap | $57.4B |
Data as of 4:02pm ET, 06/30/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -1.10% |
| Earnings growth (next 5 years) | -37.57% |
| Revenue growth (last year) | +2,191.90% |
| P/E ratio | 4.2 |
| Price/Sales | 5.95 |
| Price/Book | 4.11 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | -0.66 | -1.06% |
| BIIBBiogen | -1.19 | -0.58% |
| ILMNIllumina Inc | -2.07 | -1.11% |
| ---- |
Data as of 4:02pm ET, 06/30/2022
Financials
| Next reporting date | August 3, 2022 |
| EPS forecast (this quarter) | $4.75 |
| Annual revenue (last year) | $18.4B |
| Annual profit (last year) | $12.2B |
| Net profit margin | 66.27% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
